🇺🇸 Vitamin D3 tablets in United States

22 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 22

Most-reported reactions

1. Anaemia — 3 reports (13.64%)
2. Platelet Count Decreased — 3 reports (13.64%)
3. Alanine Aminotransferase Increased — 2 reports (9.09%)
4. Aspartate Aminotransferase Increased — 2 reports (9.09%)
5. Covid-19 — 2 reports (9.09%)
6. Dizziness — 2 reports (9.09%)
7. Neutrophil Count Decreased — 2 reports (9.09%)
8. Pneumonia — 2 reports (9.09%)
9. Rash — 2 reports (9.09%)
10. Thrombocytopenia — 2 reports (9.09%)

Source database →

Frequently asked questions

Is Vitamin D3 tablets approved in United States?

Vitamin D3 tablets does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Vitamin D3 tablets in United States?

Ain Shams University is the originator. The local marketing authorisation holder may differ — check the official source linked above.